Axon Enterprise Inc vs Barclays PLC — how do they compare? Axon Enterprise Inc trades at $548.68 (market cap $44.11B), while Barclays PLC trades at $27.92 (market cap $92.56B). The key difference: Barclays PLC is far larger — about 2.1× Axon Enterprise Inc's market cap, and Barclays PLC pays a 1.67% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | BCS | |
|---|---|---|
Market Cap | $44.11B | $92.56B |
Sector | Technology | Financials |
52-Week High | $870.97 | $28.41 |
52-Week Low | $345.94 | $18.48 |
Enterprise Value | $45.20B | — |
Dividend Yield | — | 1.67% |
Signals from Pluang's Aura AI — not financial advice
Axon Enterprise (AXON) trades at $547.03, down 3.32% on the day, with strong analyst support (81% buy ratings) and a consensus price target of $648.67. The stock shows bullish technical signals with support at $539 and resistance at $553. Recent earnings have been mixed with Q3 2025 missing estimates but Q4 2025 and Q1 2026 beating expectations. Revenue growth remains solid with 2026 projections at $3.0B and net profit margin improving to 6.9%.
Axon presents growth potential driven by strong demand for connected devices and software services, though elevated valuation ratios (P/E 220.67) pose risk. Positive sentiment stems from recent upgrades and institutional interest, including notable insider buying. Key risks include execution challenges and competitive pressures in the law enforcement technology sector.
Barclays PLC (BCS) trades at $27.29, down 0.69% on the day, near its 52-week high of $28.43. The stock shows strong fundamental momentum with revenue rising to $29.14B in 2025 and net income reaching $7.17B, supported by three consecutive quarterly EPS beats. Technical indicators signal a bullish trend, while analyst sentiment remains positive with 68% buy ratings. Recent news highlights ongoing legal investigations but also underscores the bank's role in market analysis and product innovation.
The outlook for BCS is cautiously optimistic, driven by solid earnings growth and attractive valuation metrics like a P/E of 11.91 and P/B of 0.91. Key risks include potential legal liabilities from securities investigations and macroeconomic sensitivity. Investors should weigh the strong analyst support against these headwinds for balanced decision-making.
Trailing returns across standard periods
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →